Jeff has been the CEO at Alimentiv since October 2016. In May 2018, Jeff led the successful separation of the organization from its sole owner, Western University, to a Health Trust establishing the first social enterprise of its kind in North America.
Jeff has a strong record of leading high-performing global teams that support the growth of global business units. His background in clinical research spans more than 20 years in the pharma and contract research organization (CRO) industries. Prior to his current position, he held senior positions with Alimentiv (formerly Robarts Clinical Trials) including Vice President, Clinical Operations and Director, Business Development. And before joining Alimentiv he was a Senior Director, General Medicine & Vaccines/Infectious Disease with PharmaNet (now Syneos). Jeff trained as a registered nurse, and holds a Bachelor Degree in Health Sciences (nursing).
Jeff’s perspective on building a great company has been shaped from his experience working in a variety of ownership structures including government, private, public, private equity and venture capital. These experiences helped shape his vision for building a 100-year private company that pursues its purpose and putting people first ahead of shareholder returns. In May 2018, he was able to realize this vision with the transition of ownership of Robarts Clinical Trials to a Health Trust.
“When leaders prioritize goodness in themselves and in others, they can create lasting cultures and tremendous value.”
Lisa was named a VP at Alimentiv in 2013 and subsequently named COO three years later. She succeeds by leading and partnering with other leaders to grow the business quickly in a stable way, while ensuring the company never loses sight of its purpose, people or focus.
Lisa is an organizational strategist and senior operational leader who has been focused on the professional services, health care and technology sectors for over 30 years. She has led and consulted with fast-growing and high-change organizations around the world.
Lisa’s operational knowledge, visionary perspectives and ability to connect people and ideas across many industries have helped her achieve great things with inspiring organizations and leaders. She has been part of successful start-ups, turnarounds, acquisitions or spinoffs, corporate redesigns and executive-level negotiations. She also supports or has been a board member for many charities.
“Everyone needs to be grounded by a purpose. Mine is to build strong organizations that build strong people and communities.”
Hershell has led the Clinical Research division since 2019. He is responsible for end-to-end clinical trial services and the continuous development of resources and capabilities.
Hershell has over 25 years of experience in medicine development. Prior to this role, Hershell was Senior Managing Consultant at Navitas Life Sciences and held senior roles at GSK and ICON Clinical Research where he was the Director of Clinical Process and Change Management. He also has a strong CRO services delivery background resulting from years as a clinical trials project lead and CRA.
Over the past 20 years, Hershell has defined strategy and provided leadership for major R&D process improvement and organization redesign initiatives to resolve current issues and enable future success. He drove implementation of a change management framework throughout the clinical research organization, implementing standard methodologies and tools for managing change and leading complex change initiatives to the expected benefit.
“Be authentic, breathe, listen. The time is now. There is no other opportunity than this moment to give your very best.”